神经平素-1:癌症治疗的多方面的目标
Sai Manasa Varanasi1, Yash Gulani1, Hari Krishnareddy Rachamala1
1Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL 32224, USA.
Current oncology (Toronto, Ont.)
|April 25, 2025
概括
神经皮林-1 (NRP1) 是癌症的关键调节剂,影响瘤生长,转移和患者预后. 准NRP1为个性化癌症治疗提供了一个有前途的治疗策略,目前正在进行的研究正在探索新型疗法和多omics方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 最初用于神经元引导的Neuropilin-1 (NRP1),现在被认为在癌症生物学中的重要作用.
- 在各种恶性瘤中,NRP1影响瘤进展,血管生成和治疗结果.
研究的目的:
- 审查NRP1在癌症中的多样性功能,包括其对瘤细胞增殖,迁移,入侵和转移的影响.
- 探索NRP1与关键信号通路 (VEGF,半素,TGF-β) 的相互作用及其在瘤微环境中的作用.
- 讨论NRP1作为预后生物标志物和新型癌症治疗的治疗点的潜力.
主要方法:
- 对NRP1在癌症中的功能进行文献综述.
- 分析NRP1与VEGF,半波林和TGF-β等信号通路的相互作用.
- 检查NRP1与预后的相关性及其作为治疗点的潜力.
主要成果:
- NRP1显著影响瘤细胞的增殖,迁移,入侵和转移.
- NRP1的表达与各种癌症的预后不佳有关,并促进血管生成.
- 通过抗体或抑制剂向NRP1,有望提高化疗和放射治疗的疗效.
结论:
- NRP1在癌症发病过程中发挥着关键作用,并作为潜在的预后生物标志物.
- 准NRP1为开发新型个性化癌症疗法提供了一个有前途的战略.
- 需要进一步的研究,包括多omics方法,以充分阐明NRP1的机制,并优化向治疗.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:15Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K